288 related articles for article (PubMed ID: 26687550)
21. Renal denervation in patients with resistant hypertension: six-month results.
Dores H; de Sousa Almeida M; de Araújo Gonçalves P; Branco P; Gaspar A; Sousa H; Canha Gomes A; Andrade MJ; Carvalho MS; Campante Teles R; Raposo L; Mesquita Gabriel H; Pereira Machado F; Mendes M
Rev Port Cardiol; 2014 Apr; 33(4):197-204. PubMed ID: 24472425
[TBL] [Abstract][Full Text] [Related]
22. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
Böhm M; Mahfoud F; Ukena C; Hoppe UC; Narkiewicz K; Negoita M; Ruilope L; Schlaich MP; Schmieder RE; Whitbourn R; Williams B; Zeymer U; Zirlik A; Mancia G;
Hypertension; 2015 Apr; 65(4):766-74. PubMed ID: 25691618
[TBL] [Abstract][Full Text] [Related]
23. [Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology].
Vonend O; Böhm M; Eckert S; Hausberg M; Rittger H; Rump LC; Schmieder R; Schulte KL; Schunkert H; Uder M; Veelken R; Vorwerk D; Weil J; Wenzel U; Mahfoud F
Dtsch Med Wochenschr; 2015 Mar; 140(5):363. PubMed ID: 25734680
[TBL] [Abstract][Full Text] [Related]
24. [Renal denervation 2013].
Spinar J; Vítovec J; Spinarová L
Vnitr Lek; 2013 Aug; 59(8):724-9. PubMed ID: 24007231
[TBL] [Abstract][Full Text] [Related]
25. Renal denervation.
Olsen LK; Kamper AL; Svendsen JH; Feldt-Rasmussen B
Eur J Intern Med; 2015 Mar; 26(2):95-105. PubMed ID: 25676808
[TBL] [Abstract][Full Text] [Related]
26. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
[TBL] [Abstract][Full Text] [Related]
27. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
Sievert H; Schofer J; Ormiston J; Hoppe UC; Meredith IT; Walters DL; Azizi M; Diaz-Cartelle J; Cohen-Mazor M
EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197
[TBL] [Abstract][Full Text] [Related]
28. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Davies J; Basile J; Kirtane AJ; Wang Y; Lobo MD; Saxena M; Feyz L; Rader F; Lurz P; Sayer J; Sapoval M; Levy T; Sanghvi K; Abraham J; Sharp ASP; Fisher NDL; Bloch MJ; Reeve-Stoffer H; Coleman L; Mullin C; Mauri L;
Lancet; 2018 Jun; 391(10137):2335-2345. PubMed ID: 29803590
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous renal sympathetic denervation: 2013 and beyond.
Froeschl M; Hadziomerovic A; Ruzicka M
Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191
[TBL] [Abstract][Full Text] [Related]
30. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
[TBL] [Abstract][Full Text] [Related]
31. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
32. Renal denervation for resistant hypertension and beyond.
Laffin LJ; Bakris GL
Adv Chronic Kidney Dis; 2015 Mar; 22(2):133-9. PubMed ID: 25704350
[TBL] [Abstract][Full Text] [Related]
33. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial.
Kandzari DE; Bhatt DL; Sobotka PA; O'Neill WW; Esler M; Flack JM; Katzen BT; Leon MB; Massaro JM; Negoita M; Oparil S; Rocha-Singh K; Straley C; Townsend RR; Bakris G
Clin Cardiol; 2012 Sep; 35(9):528-35. PubMed ID: 22573363
[TBL] [Abstract][Full Text] [Related]
34. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
Epstein M; de Marchena E
J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
[TBL] [Abstract][Full Text] [Related]
35. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
[TBL] [Abstract][Full Text] [Related]
36. [Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment].
Mahfoud F; Vonend O; Bruck H; Clasen W; Eckert S; Frye B; Haller H; Hausberg M; Hoppe UC; Hoyer J; Hahn K; Keller T; Krämer BK; Kreutz R; Potthoff SA; Reinecke H; Schmieder R; Schwenger V; Kintscher U; Böhm M; Rump LC;
Dtsch Med Wochenschr; 2011 Nov; 136(47):2418. PubMed ID: 22048949
[TBL] [Abstract][Full Text] [Related]
37. [Position paper on the results of Symplicity HTN-3 trial. Grupo de estudio de la hipertensión arterial resistente].
Azpiri-López JR; Assad-Morell JL; Ponce de León-Martínez E; Monreal-Puente R; Dávila-Bortoni A; Vázquez-Díaz LA; Treviño-Frutos RJ; Barrera-Oranday F; Del Angel-Soto JG; Martínez JG; Arellano-Torres M
Arch Cardiol Mex; 2015; 85(2):154-7. PubMed ID: 25700579
[TBL] [Abstract][Full Text] [Related]
38. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.
Esler MD; Krum H; Schlaich M; Schmieder RE; Böhm M; Sobotka PA;
Circulation; 2012 Dec; 126(25):2976-82. PubMed ID: 23248063
[TBL] [Abstract][Full Text] [Related]
39. Renal Denervation in the Management of Resistant Hypertension: A Comprehensive Review of Literature.
Salehin S; Karnkowska B; Hamza I; Malik H; Syeda D; Hasan SM; Rangasetty U; Gilani S; Jneid H; Raja M
Curr Probl Cardiol; 2024 Feb; 49(2):102137. PubMed ID: 37863457
[TBL] [Abstract][Full Text] [Related]
40. An update on renal artery denervation and its clinical impact on hypertensive disease.
Bhat A; Kuang YM; Gan GC; Burgess D; Denniss AR
Biomed Res Int; 2015; 2015():607079. PubMed ID: 26495305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
